Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT03355976
Title BrUOG 354 Nivolumab +/- Ipilimumab for Ovarian and Extra-renal Clear Cell Carcinomas
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Don Dizon
Age Groups: senior | adult
Covered Countries USA

No variant requirements are available.